Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Moodys
Chinese Patent Office
Covington
Citi
Cerilliant
McKinsey
Deloitte

Generated: July 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016191

« Back to Dashboard

NDA 016191 describes SORBITRATE, which is a drug marketed by Astrazeneca and is included in six NDAs. Additional details are available on the SORBITRATE profile page.

The generic ingredient in SORBITRATE is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
Summary for 016191
Tradename:SORBITRATE
Applicant:Astrazeneca
Ingredient:isosorbide dinitrate
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 016191

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;SUBLINGUALStrength5MG
Approval Date:Apr 1, 1996TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;SUBLINGUALStrength2.5MG
Approval Date:Apr 1, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chinese Patent Office
UBS
Citi
AstraZeneca
Chubb
Argus Health
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.